Search

everythinglearnresearchcommunity

for

Search:↓

Applying a DNA vaccine to skin with active hair growth boosts immune response and protection against anthrax in mice.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

DOPE:DOPC liposomes can improve targeted cancer drug delivery, reducing side effects and increasing effectiveness.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Nanocarriers improve skin disease treatment by targeting hair follicles effectively.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Imiquimod shows promise as a non-invasive treatment for certain HPV-related lesions, but more research is needed to optimize its use.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Microneedles offer a painless, precise, and versatile method for drug delivery and disease treatment.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Gambogic Amide helps maintain hair color and promotes hair growth.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Injecting monocyto-angiotropin into hare skin increases hair growth by forming new blood vessels.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Smart microneedles improve hair loss treatment by delivering drugs precisely with fewer side effects.

New treatments for lupus show promise, but more research is needed, especially for children.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

EV-based drug delivery shows promise but faces challenges in standardization and scalability.

Repurposing existing drugs can quickly and cheaply find new treatments for unmet medical needs.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

Bubble-based systems show promise for precise, targeted drug delivery and diagnosis, especially in cancer treatment.